Kotak Upgrades #Mankind Pharma to Buy; Sets ₹3,000 Target on Strong… — VLuxe Live News — TG.ME

VLVLuxe Live News@vluxelive · 86 subscribersOpen in TelegramOpen

📈 Kotak Upgrades #Mankind Pharma to Buy; Sets ₹3,000 Target on Strong Domestic Growth

👉🏻 Rating: Upgraded to Buy with ₹3,000 target price
👉🏻 Sales: Domestic secondary sales grew 14.6% YoY in July–August
👉🏻 Outperformance: Growth ran ~120 bps ahead of the Indian pharma market
👉🏻 Earnings: Kotak expects ~23% EPS CAGR over FY26–29E
👉🏻 Upside: Target implies ~23% potential upside from recent levels
#MankindPharma #KotakSecurities #Pharma #BrokerageCall

t.me/vluxelive/777

2

1

September 22, 2026 23